Julie Wolf Selected Research

Julie Wolf Research Topics

5	Neoplasms (Cancer) 02/2012 - 08/2006
3	Adenocarcinoma 01/2020 - 07/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2012 - 08/2006
3	Exanthema (Rash) 03/2009 - 08/2006
3	Diarrhea 03/2009 - 08/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 07/2007
1	Genomic Instability 01/2020
1	Injection Site Reaction 01/2018
1	Cellulitis 12/2017
1	Uveal melanoma 01/2010
1	Melanoma (Melanoma, Malignant) 01/2010
1	Sepsis (Septicemia) 12/2006
1	Fatigue 03/2006

5	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2012 - 08/2006
4	Gemcitabine FDA Link 01/2020 - 03/2006
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 12/2017
2	VaccinesIBA 01/2018 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 12/2006
1	Histones (Histone)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	MethyltransferasesIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 12/2017
1	AnticoagulantsIBA 12/2017
1	VimentinIBA 02/2012
1	Cadherins (E-Cadherin)IBA 02/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	Peptides (Polypeptides)IBA 01/2010
1	HLA-A Antigens (HLA-A)IBA 01/2010
1	Histocompatibility Antigens Class IIIBA 01/2010
1	SmokeIBA 03/2009
1	Carboplatin (JM8)FDA LinkGeneric 12/2006
1	Biological ProductsIBA 12/2006
1	Pharmaceutical PreparationsIBA 08/2006
1	NucleosidesIBA 03/2006
1	4'-thio-arabinofuranosylcytosineIBA 03/2006

2	Therapeutics 12/2017 - 02/2012
1	Subcutaneous Injections 12/2017